| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.6 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.6 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.095 | 0.6 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.6 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |